Dashboard
Gemmus PHARMA
San Francisco, CA
Gemmus is a privately held biotechnology company focused on the development of innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases. Using a novel, host-directed approach, we target the underlying cause of debilitating symptoms associated with influenza and 'influenza-like-illness' (ILI) by modulating the natural immune response to the disease. We are committed to developing "first-in-class, best-in-class" products that meet a major medical need.
VISIT WEBSITE